Oct 6, 2013
Executive Q&A: BioMimetic founder Samuel Lynch promotes life sciences in TN
Samuel Lynch brought his life sciences company to Nashville from Boston more than 10 years ago.
FDA rejection of bone graft a setback for Wright Medical Group
Former shareholders in BioMimetic Therapeutics Inc. stand to lose tens of millions of dollars in payments from acquirer Wright Medical Group Inc. that were contingent on U.S. Food and Drug Administration approval of the biotech firm's key product.
Wright Medical completes $380M acquisition of BioMimetic Therapeutics
Wright Medical Group Inc. has finalized its $380 million purchase of Franklin-based BioMimetic Therapeutics Inc.
BioMimetic Therapeutics Rating Lowered to Neutral at Summer Street
Separately, analysts at Zacks downgraded shares of BioMimetic Therapeutics from an "outperform" rating to a "neutral" rating in a research note to investors on Tuesday, January 8th.